Next Generation Migraine Therapies

The Next Generation Migraine Therapies (NGMT) initiative is a comprehensive program designed to provide a multi-faceted approach to migraine education offered at no cost to healthcare providers. Brought to you by the American Headache Society, the program covers diagnosis and treatment of migraine, and updates on the latest science. Through a mix of regional in-person workshops, NGMT is designed to engage participants through didactic and case study workshops, including interactive education elements, communication toolkits, and takeaway resources.

View the preliminary program brochure here.

UPDATE: NGMT programs in Seattle, Salt Lake City and Chicago have been rescheduled to Fall 2020.

Salt Lake City – September 12, 2020

Chicago – September 26, 2020

Seattle – October 31, 2020

AHS gratefully acknowledges the educational support of the Next Generation Migraine Therapies Program from our industry supporters:

Allergan, Inc.
Eli Lilly and Company